Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients

NEXT STORY
Sensus Healthcare to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th
PREV STORY
Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

George Bickerstaff Elected to Inovio’s Board of Directors

PLYMOUTH MEETING, Pa., March 21, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...

author_avatar
NASDAQ Market News

BioAdaptives, Inc Names Dr. James Rouse as President

LAS VEGAS, May 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC PINK:BDPT) announced Dr. ...

author_avatar
NASDAQ Market News

XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis

AUSTIN, Texas, June 09, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

author_avatar
NASDAQ Market News